Anika Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview

Anika Therapeutics

05/08/2023 02:17

* Anika Therapeutics Inc  ANIK.OQ   ANIK.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 8. 
    * The Bedford Massachusetts-based  company is expected to
report 
a 2.3% increase in revenue to $40.557 million from $39.66
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Anika Therapeutics
Inc is
for a loss of 27 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Anika
Therapeutics Inc is $33​, above​ its last closing price
of $22.02. ​​​

This summary was machine generated August 5 at 01:17 GMT.  All
figures in US dollars  unless otherwise stated